Fibromyalgia:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIIR2014310)
◆英語タイトル: Fibromyalgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
◆発行会社/調査会社:DelveInsight
◆商品コード:DIIR2014310
◆発行日:2014年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:75以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD2,000 ⇒換算¥218,000見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD6,000 ⇒換算¥654,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Fibromyalgia:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s, “ Fibromyalgia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India. The research, analysis also presents the global sales forecasts data till 2015. The report is also giving insight about the patent and exclusivity details of all the drugs across the indication.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


• A snapshot of the global Market therapeutics scenario for Fibromyalgia.
• A review of the marketed products under prescription for Fibromyalgia, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Fibromyalgia with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
• Coverage of API Manufacturers for Fibromyalgia drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Fibromyalgia drugs.
• Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Fibromyalgia drugs.
• Coverage of Fibromyalgia Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
• Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2011-2015.

• Evaluate the marketing status and exclusivity details of Fibromyalgia key products to exploit opportunities for generic drug development opportunities.
• Identify and understand important and diverse types of therapeutics under Phase III development for Fibromyalgia.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Fibromyalgia.
• API intelligence over marketed drugs for Fibromyalgia and gaining primary intelligence over active ingredients manufacturers across the globe.
• API intelligence over leading Phase III pipeline drugs.
• Develop and designstrategies by identifying the API manufacturers for Phase III pipeline products to enhance and expand business potential and scope.
• Understanding the scope of the Phase III Drugs with nil regulatory filings.
• Understanding the chemical route of synthesis of approved drugs for Fibromyalgia.
• Uncovering opportunities in the rapidly growing the US markets.

*** レポート目次(コンテンツ)***

• Indication Overview
• Marketed Drugs Assessment
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing Status
• Marketed Details of Drugs by Patent Expiration Timeline
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment
• The API Manufacturers by the United States Drug Master File (US DMF) Status
• The API Manufacturers by the US DMF Status (Drug Specific)
• The Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
• The API Manufacturers by the US DMF Status (Drug Specific)
• Drugs Market Data and Forecasted Sales Figures (2011-2015)
• Marketed Drugs Information
• Drugs Description
• Route of Synthesis
• Global Active Pharmaceutical Manufacturers
• Approval Status
• Patent and Exclusivity Details
• Company Overview
• Phase III Drugs Information
• Phase III Drugs Description
• The United States Drug Master Filings (US DMF)
• Discontinued Drugs Information

Fibromyalgia Therapeutic Market, US, Marketed Drugs by Application Type, 2014
Fibromyalgia Therapeutic Market, US, Marketed Drugs by Marketing Status, 2014
Fibromyalgia Therapeutic Market, US, (Year), 2014
Fibromyalgia Marketed Drugs, API Manufacturers by US DMF Status, 2014
Fibromyalgia Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Fibromyalgia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Fibromyalgia Therapeutic Market, Global Sales (in million USD), 2014
Fibromyalgia Marketed Drugs, API Manufacturers, Global, 2014
Fibromyalgia Phase III Pipeline Drugs, United States Drug Master File (DMF), 2014
Discontinued Drugs for Fibromyalgia, 2014

Fibromyalgia Therapeutic Market, US, Marketed Drugs by Application Type (%), 2014
Fibromyalgia Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2014
Fibromyalgia Therapeutic Market, US, (Year), 2014
Fibromyalgia Marketed Drugs, API Manufacturers by US DMF Status (%), 2014
Fibromyalgia Marketed Drugs, US DMF Status Drug Specific (Number), 2014
Fibromyalgia Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2014
Fibromyalgia Therapeutic Market, Global Sales (in million USD), 2014
Fibromyalgia Marketed Drugs, Patent/Exclusivity Expiry (Year), 2014

*** 掲載企業 ***

Pfizer Inc.
Eli Lilly and Company
Royalty Pharma

*** レポートのキーワード ***

Fibromyalgia、医薬品、治療薬、規模、販売量、医薬品有効成分(API)メーカー、第Ⅲ相試験、製薬

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • P2 Energy Solutions(石油・ガス分野):企業のM&A・提携動向
    Summary P2 Energy Solutions (P2 Energy) is a solution provider in the oil and gas utility sector. The company operates through its segments, oil and gas accounting, mid-stream solutions, land asset management, map data, and operating and engineering. It develops BOLO, entelligent, enterprise upstrea …
  • プリンテッドエレクトロニクスの世界市場2017-2021
    About Printed ElectronicsPrinted electronics is a set of printing methods, which is used to create electrical devices on different substrates such as plastic, ceramic, and textiles Technavio’s analysts forecast the global printed electronics market to grow at a CAGR of 8.26% during the period 2017-2 …
  • 油脂(食品)市場:キルギス(~2017)
    Synopsis "Oils and Fats Market in Kyrgyzstan: Databook to 2017" is the result of Canadean's extensive market research covering the Oils and Fats market in Kyrgyzstan. The report presents detailed historic and forecast data on the Oils and Fats consumption trends in Kyrgyzstan, offering consumption v …
  • UAVフライトコントローラの世界市場
    UAV Flight Controllers Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, …
  • インスリンポンプの北米市場:市場展望・シェア・動向・成長・需要予測
    North America Insulin Pump Market is likely to reach more than US$ 4.2 Billion by the year end of 2022. Long–term Growth Projection: • Number of diabetes population in United States will increase to more than 33 Million by the year end of 2022 • In 2016, there were more than 5,00,000 insulin pump us …
  • カタールの硫黄市場2016-2020
    About The report brings together facts and figures about sulfur market in Qatar covering period of 2010-2020. Statistics, experts’ opinions and estimations are given. The report about sulfur market in Qatar covers: - reserves, mines, production - manufacturers - demand structure, trends - consumers …
  • 世界のMEMS圧力センサー市場動向(2012-2016)
    TechNavio's analysts forecast the Global MEMS Pressure Sensors market to grow at a CAGR of 8.84 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand in the Automotive segment. The Global MEMS Pressure Sensors market has also been witne …
  • マヌカハニーのヨーロッパ市場:メーカー別、種類別、用途別、市場予測(~2022)
    Manuka honey, produced in Australia and New Zealand by bees that pollinate the Manuka bush, is one of the most unique and beneficial forms of honey in the world. The honey is commonly sold as an alternative medicine. There are many Manuka honey uses that range from healing sore throats and digestive …
  • 半導体CVD(化学気相成長)装置の世界市場2016-2020
    Covering: This industry research report includes a detailed segmentation of the global semiconductor CVD equipment market by product type (AP CVD, DP CVD, LP CVD, and MO CVD) and by end user (foundry, memory, and IDM). It also outlines the market shares for key regions such as APAC, Europe, and Nort …
  • 世界の真空計市場:企業別、地域別、製品種類・用途別分析
    The global Vacuum Gauge market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. This report offers an overview of the market trends, drivers, and barriers with respect to the Vacuum Gauge market. It also p …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIIR2014310 )"Fibromyalgia:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)" (英文: Fibromyalgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。